Ticker
VTGNCompany Name
VISTAGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -55.77M | -8633.59% | $ 646K |
3/31/2025 | $ -51.41M | -10578.4% | $ 486K |
12/31/2024 | $ -47.3M | -6773.01% | $ 698.3K |
9/30/2024 | $ -39.56M | -4517.15% | $ 875.7K |
6/30/2024 | $ -33.19M | -3420.28% | $ 970.4K |
3/31/2024 | $ -29.36M | -2759.21% | $ 1.06M |
12/31/2023 | $ -32.06M | -3076.34% | $ 1.04M |
9/30/2023 | $ -35.48M | -4377.06% | $ 810.5K |
6/30/2023 | $ -46.37M | 0% | $ -359.7K |
3/31/2023 | $ -59.24M | 0% | $ -227.3K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for VISTAGEN THERAPEUTICS INC is calculated as follows: EBIT [ $ -15.64M ] / Revenues [ $ 334K ]
(=) EBIT % [ -4682.96% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |